Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals
Published:
|
Updated:
Changes
- : Revised guidelines
Guidelines
The guidelines and associated template for submission must be used when preparing and submitting documentation for single technology assessments of medicinal products for decisions regarding public sector funding via the National Insurance scheme (“Blåresept”) and the Regional Health Authorities ("Nye metoder").
The guidelines were last revised in November 2023, see news post for details.
Submission Guidelines
Documentation in compliance with the previous version of the guidelines will be accepted in a transition period of 6 months.